Skip to main content

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

AbCellera Biologics Inc. - Business Wire - Tue Oct 7, 2025

AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:

  • Truist Securities BioPharma Symposium, November 6, 2025
  • Stifel Healthcare Conference, November 11-13, 2025
  • Jefferies Global Healthcare Conference, November 18-20, 2025
  • Piper Sandler 37th Annual Healthcare Conference, December 2-4, 2025

Visit AbCellera's Investor Relations website for additional information.

About AbCellera Biologics Inc .

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com .

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).